- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Call
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Shabih Shakeel
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Mark Eaton
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marco Herold
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sant-Rayn Pasricha
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A new regulator of 'stemness' to create dendritic cell factories for immunotherapy
- Advanced imaging interrogation of pathogen induced NETosis
- Cancer driver deserts
- Cryo-electron microscopy of Wnt signalling complexes
- Deciphering the heterogeneity of breast cancer at the epigenetic and genetic levels
- Developing drugs to block malaria transmission
- Developing new computational tools for CRISPR genomics to advance cancer research
- Developing novel antibody-based methods for regulating apoptotic cell death
- Discovering novel paradigms to cure viral and bacterial infections
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Do membrane forces govern assembly of the deadly apoptotic pore?
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- E3 ubiquitin ligases in neurodegeneration, autoinflammation and cancer
- Engineering improved CAR-T cell therapies
- Epigenetic biomarkers of tuberculosis infection
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- Genomic rearrangement detection with third generation sequencing technology
- How does DNA damage shape disease susceptibility over a lifetime?
- How does DNA hypermutation shape the development of solid tumours?
- How platelets prevent neonatal stroke
- Human lung protective immunity to tuberculosis
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of dysregulated Tom40 in neurodegeneration
- Investigating the role of mutant p53 in cancer
- Lupus: proteasome inhibitors and inflammation
- Machine learning methods for somatic genome rearrangement detection
- Malaria: going bananas for sex
- Measurements of malaria parasite and erythrocyte membrane interactions using cutting-edge microscopy
- Measuring susceptibility of cancer cells to BH3-mimetics
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Mutational signatures of structural variation
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Revealing the epigenetic origins of immune disease
- Reversing antimalarial resistance in human malaria parasites
- Structural and functional analysis of DNA repair complexes
- Targeting human infective coronaviruses using alpaca antibodies
- Towards targeting altered glial biology in high-grade brain cancers
- Uncovering the real impact of persistent malaria infections
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding how malaria parasites sabotage acquisition of immunity
- Understanding malaria infection dynamics
- Understanding the mechanism of type I cytokine receptor activation
- Unveiling the heterogeneity of small cell lung cancer
- Using alpaca antibodies to understand malaria invasion and transmission
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to cross the blood brain barrier for drug delivery
- Using structural biology to understand programmed cell death
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
HIV

Human Immunodeficiency Virus (HIV) infection places an immense burden on global health. The virus causes Acquired Immune Deficiency Syndrome (AIDS) by depleting infection-fighting immune cells. There are medications that are effective in preventing people with HIV developing AIDS, but no cure. Our researchers are working to improve how HIV is treated, with the goal of curing this infection.
HIV research at WEHI
Our researchers aim to improve treatments for people infected with HIV. Their focuses are:
- Revealing why the immune system cannot clear HIV from the body.
- Developing new ways to enhance the immune response against HIV, as a potential cure.
Our researchers also investigate many significant illnesses that affect people with AIDS, including:
What are HIV and AIDS?
HIV is a virus, meaning it can only reproduce within another organism’s cells. HIV reproduces in certain human immune cells, particularly a type of immune cell called CD4 T cells. These cells are critical for many immune responses that protect against infections.
When a person is infected with HIV, they may initially be healthy and not realise they are carrying the virus. Without treatment, people infected with HIV usually stay healthy for around 10 years. However, the infection gradually kills their CD4 T cells. This means their immune system cannot function properly.
Someone infected with HIV and not receiving treatment will eventually develop a condition called Acquired Immune Deficiency Syndrome (AIDS). In this condition, the loss of CD4 T cells means the person’s immune system cannot fight infections. People with AIDS are at risk of severe infections by viruses, bacteria and fungi. Often these are infections that a healthy immune system can prevent. A person with AIDS will ultimately die from an overwhelming infection.
More than 27,000 Australians are infected with HIV. Most of these people receive appropriate treatment. This prevents their disease progressing to AIDS. The Education and Resource Centre at the Alfred provides support and information for Victorians living with HIV.
Globally, around 37.9 million people are infected with HIV. The majority of people living with HIV are aged 15 to 49. AIDS-related illnesses cause 770,000 deaths annually, mostly in resource-poor communities. HIV infection is an enormous health, social and economic burden globally.
How is HIV spread?
HIV is a type of virus called a retrovirus. It consists of:
- An outer membrane, or envelope, made of lipids and proteins
- The virus’s genetic content, or genome. This is made of the DNA-like molecule, RNA.
- Internal proteins that help the virus infect cells.
HIV can be transmitted between people through contact with infected bodily fluids. The main sources of HIV infection globally are:
- HIV-infected blood: In Australia, blood donations are screened to ensure they do not contain HIV or other viruses. Syringe needles contaminated with HIV are another potential source of infection.
- Sexual contact: HIV is present in semen and vaginal fluids.
- From mother to child: during pregnancy or birth, or through infected breast milk. This can be reduced by medical interventions including appropriate medical treatment of pregnant women infected with HIV.
When an HIV viral particle enters the body it can infect immune cells called CD4 T cells.
The stages of HIV infection of CD4 T cells are:
- Entry into the cell: The virus binds to certain proteins on the outside of CD4 T cells. This allows the viral proteins and genome to enter the cell.
- Reverse transcription: A viral protein converts the viral genome, made of RNA, to DNA. The genome of human cells is made of DNA.
- Integration: The viral DNA joins into the cell’s DNA. This allows the virus to hide within the cell. It may lie dormant for several years.
- Production of new viruses: The HIV DNA within the cell directs the formation of new viral genomes and proteins. These assemble into new viral particles.
- Release from the cell: The new HIV particles leave the cell, and can infect other cells.
Not all CD4 T cells that are infected with HIV go on to produce new viruses. Often, the CD4 T cells will detect the viral DNA that is produced by reverse transcription. This can trigger the death of the infected cell as a protective response.
How is HIV treated?
There is currently no cure for HIV, and no preventive vaccine.
Understanding how HIV infects cells has led to anti-viral medications that block the different stages. These agents prevent HIV from spreading between cells within the body. This stops the loss of CD4 T cells, allowing the HIV-infected person to stay healthy.
People infected with HIV can receive lifelong anti-viral treatments that stop the loss of CD4 T cells. This prevents AIDS, and allows a near-normal life. Appropriate treatment can also reduce the chance that someone infected with HIV infects other people, particularly for mother to child transmission. Anti-viral treatments can also prevent HIV infections if given immediately after exposure.
When HIV replicates, its genome and proteins may slightly change (mutate). Occasionally these changes mean that the new HIV viral particles are resistant to the actions of an anti-viral medication. If this occurs, the resistant virus will spread unhindered in the body, and the treatment will be ineffective. The best strategies to treat HIV use several different anti-viral medications at once. This reduces the chance that resistance to one treatment can occur.
In poorer communities, the cost of long-term treatment for HIV can prevent people from accessing the best treatment. This increases the chance that they will develop AIDS and die. There is an urgent need for a cure or preventive vaccine for HIV.
Researchers:
Super Content:
What new discoveries and treatments are on the horizon for infectious diseases? Catch up with the discussion from this public talk.
A newly discovered gene could hold the key to treating and potentially controlling HIV, hepatitis and tuberculosis.
Sylvia and Charles Viertel Fellowship to support Professor Marc Pellegrini's research into HIV, tuberculosis and hepatitis B